Plausibility referral epo
Webb11 jan. 2024 · Post-Published Evidence and Plausibility With regard to the admissibility of post-published evidence to support inventive step, the Board of Appeal considered there … WebbPlausibility at the EPO – good news for innovators? - Carpmaels & Ransford - Law Firm In a welcome decision for patentees, an EPO pharmaceutical Board of Appeal establishes …
Plausibility referral epo
Did you know?
Webb⚖️ G 2/21 #plausibility has been decided! The #epo Enlarged Board of Appeal came up with an “it depends on the techncial filed”-type of decision, which luckily still fits our visuals 😉 ... Webb31 mars 2024 · The issue of plausibility was previously referred to the Enlarged Board of Appeal (EBA), the highest judicial authority at the European Patent Office (EPO). Our article on the referral can be found here. The oral proceedings for G2/21 took place in Munich on 24 November 2024 and our article summarising the preliminary opinion can be found here.
Webb2 nov. 2024 · Over time, the EPO has also adopted a stance that technical effects/advantages must be at least plausibly demonstrated in a patent application as originally filed. Otherwise, objections under Article 56 EPC (inventive step) or Article 83 EPC (sufficiency of disclosure) may be raised. Webb11 okt. 2024 · With regard to the disputed requirement of plausibility, the board indicated that a referral to the Enlarged Board of Appeal might be necessary. VII. By letter dated 19 April 2024, the appellant withdrew its previously …
Webb18 nov. 2024 · The referring decision of the Board of Appeal makes reference to a quote from Sir Robin Jacob on plausibility which suggests that the requirement is based on an interpretation of the European Patent Convention that is not actually supported by the words of the Convention. Webb27 mars 2024 · The background to this Decision and the referral to the EBA is explained in our earlier article "Plausibility - EPO stays proceedings in view of Enlarged Board Referral".
Webb20 okt. 2024 · We reported in August 2024 that the EPO’s Enlarged Board of Appeal (EBA) would be considering the doctrine of plausibility at the EPO. We further reported in …
Webb25 nov. 2024 · Oral Proceedings for G2/21 were held on 24 November 2024 before the Enlarged Board of Appeal (EBA) to discuss plausibility and the admissibility of post-published evidence in proceedings before the EPO. In brief: no decision was announced during the oral proceedings. panchito cantinaWebbThe President of the EPO has decided that, in view of the potential impact of the referral, all examination and opposition proceedings before the EPO in which the decision depends … panchito caoWebbA referral has now been made to the EPO’s Enlarged Board of Appeal asking it to clarify the law concerning the doctrine of ‘plausibility’ and the use of post-filed data to support inventive step.. BACKGROUND. In our previous article, we reported that the EPO’s Boards of Appeal were expected to request clarification from the Enlarged Board of Appeal on the … エコリング オークション 紹介Webb28 mars 2024 · After a lengthy review of EPO case law which the referring TBA found divergent because different standards were applied to plausibility (i.e. in order of … エコリングオークション 紹介WebbThe EBA referral arose from appeal proceedings relating to European Patent No. 2484209 (Sumitomo Chemical Company, Limited), which had been opposed by Syngenta Limited. Sumitomo and Syngenta presented arguments and answered questions from the Board at the hearing. Representatives for the EPO President also contributed. エコリング オークション 年会費Webb23 mars 2024 · European patent EP 2 484 209 concerns an insecticide composition for controlling an insect pest. According to the patent, two compounds which were already … エコリング オークション 紹介キャンペーンWebb28 okt. 2024 · The issue of plausibility has now been formally referred to the highest judicial authority at the EPO to clarify the circumstances in which post-filed data can be … エコリング オークション 評判